Lupin Ltd — Capital/Financing Update 2022

Aug 24, 2022

August 24, 2022

==> picture [84 x 99] intentionally omitted <==

 BSE Limited

Department of Corporate Services, P. J. Towers, Dalal Street, Mumbai Samachar Marg, MUMBAI - 400 001.

National Stock Exchange of India Limited

Exchange Plaza, Bandra Kurla Complex, Bandra (East), MUMBAI - 400 051.

Sub: Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir/Madam,

We are pleased to announce that the Company has entered into Deed of Assignment with Boehringer Ingelheim International GmbH for the acquisition of brands Ondero and Ondero - Met (including trademark rights associated with the brands), which will enable the Company to provide comprehensive and best-in-class treatment options for diabetes management. Particulars are as under: -

- Name of the Acquirer Lupin Limited

==> picture [483 x 325] intentionally omitted <==

----- Start of picture text -----

a) name of the target entity, details in brief such as size, turnover Acquisition of brands
etc.; ‘Ondero’ and ‘Ondero
Met’ from Boehringer
Ingelheim International
GmbH.
b) whether the acquisition would fall within related party No.
transaction(s) and whether the promoter/ promoter group/
group companies have any interest in the entity being
acquired? If yes, nature of interest and details thereof and
whether the same is done at ‘arms-length’;
c) industry to which the entity being acquired belongs; Pharmaceuticals.
d) objects and effects of acquisition (including but not limited to, The brands relate to
disclosure of reasons for acquisition of target entity, if its medicines for the diabetic
business is outside the main line of business of the listed entity); segment. Value creation is
expected for Lupin’s
diabetic portfolio.
e) brief details of any governmental or regulatory approvals No government/regulatory
required for the acquisition; approvals are required.
f) indicative time period for completion of the acquisition; August 2023.
g) nature of consideration - whether cash consideration or share Cash consideration.
swap and details of the same;
h) cost of acquisition of brands; Euro 26 million.
----- End of picture text -----

Registered Office: 3[rd] Floor, Kalpataru Inspire, Off W. E. Highway, Santacruz (East), Mumbai - 400 055 India. Tel: (91-22) 6640 2323. Corporate Identity Number: L24100MH1983PLC029442 www.lupin.com

www.lupin.com

==> picture [84 x 99] intentionally omitted <==

==> picture [483 x 33] intentionally omitted <==

----- Start of picture text -----

i) percentage of shareholding / control acquired and / or N/A.
number of shares acquired; and
----- End of picture text -----

j)	brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief).	Boehringer Ingelheim International GmbH is a company incorporated under the laws of Germany. It is engaged in the pharmaceutical industry.

This may kindly be considered as a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above is for your information and dissemination.

Thanking you,

For LUPIN LIMITED

Rajvardhan Vishnu Satam

Digitally signed by Rajvardhan Vishnu Satam DN: c=IN, st=Maharashtra, 2.5.4.20=c19d8ef961d9fa59e973a093a4d3924b2532eb2f496ea7e2abcf7470 0f5375b7, postalCode=400104, street=2404,SEJAL TOWER,SEJAL PARK,LINK ROAD,GOREGAON WEST,Mumbai,Motilal Nagar,Borivali,Mumbai Suburban, pseudonym=9a4b7cd219ea516ad56e6d651dcbbe5b, title=0191, serialNumber=df8ebe60a88c796663c738ea25bfa0b475d195f726cdb67a2ff0 9c4242771b2a, o=Personal, cn=Rajvardhan Vishnu Satam Date: 2022.08.24 22:23:17 +05'30'

R. V. SATAM COMPANY SECRETARY (ACS -11973)

Registered Office: 3[rd] Floor, Kalpataru Inspire, Off W. E. Highway, Santacruz (East), Mumbai - 400 055 India. Tel: (91-22) 6640 2323. Corporate Identity Number: L24100MH1983PLC029442 www.lupin.com

www.lupin.com